Broadly Neutralizing Antibody-Secreting T Cells and CAR-Ts Potently Suppress In Vivo HIV Infection
Background: We hypothesized that combining anti-HIV CAR-T cells and with T cells engineered to secrete broadly neutralizing antibodies (bNAbs) could provide an approach to achieve ART-free HIV remission. As a proof-of-concept, we engineered a lentiviral vector (LV) encoding 3BNC117 bNAb (3BNC) to transduce T cells. We further evaluated the in vivo synergistic effects of 3BNC-expressed…